Seekingalpha

Published September 14, 2026

NRx Pharmaceuticals: Promising Ketamine Opportunity In Psychiatry (NASDAQ: NRXP)

Read the full story at Seekingalpha

KETAFREE can turn NRx Pharmaceuticals' ketamine opportunity into a commercial business, provided FDA approval leads to a successful launch.